1. Randomized clinical trials and COVID-19: managing expectations.;Bauchner;JAMA
2. Preserving clinical trial integrity during the coronavirus pandemic.;McDermott;JAMA
3. Addressing missing data in clinical trials.;Fleming;Ann Intern Med,2011
4. US Food and Drug Administration. FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency: Guidance for Industry, Investigators, and Institutional Review Boards. March 2020 (updated May 14, 2020). US Dept of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, Oncology Center of Excellence, Office of Good Clinical Practice. Accessed May 21, 2020. Docket No. FDA-2020-D-1106.? https://www.fda.gov/media/136238/download